Donley Matthew Maxwell
SEC CIK 1636642 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals Inc. | Ex VP, Internal Ops | 680.3K | $46.6K | $1.26M | 13 | 2022-03-02 | 2026-03-02 |
Most active insiders at AUPH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | TANG KEVIN | Dir | $25.14M | — |
| 2 | Robertson Stephen P. | EVP, GC | — | $546.4K |
| 3 | Cole Ryan | COO | — | — |
| 4 | Keenan Greg | SVP, Chief Medical Off | — | — |
| 5 | Hearne Michael S | CFO | — | — |
| 6 | Miller Joseph M | CFO | — | — |
| 7 | Donley Matthew Maxwell | COO | — | — |
| 8 | Bailey Jeffrey Allen | Dir | — | — |
| 9 | Johnson Craig A | Dir | — | — |
| 10 | Greenleaf Peter | CEO, Dir | — | — |
Transactions 13
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2026-03-03 | 2026-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | F - Tax | $14.21 | -40.8K | 680.3K | -6% | -$579.2K |
| D | 2026-03-03 | 2026-02-27 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +58.2K | 721.1K | +9% | $0 |
| 2026-02-23 | 2026-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | F - Tax | $14.40 | -32.9K | 662.9K | -5% | -$473.8K | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | F - Tax | $15.95 | -42.8K | 695.8K | -6% | -$682.5K | |
| 2026-01-05 | 2026-01-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +54.2K | 734.6K | +8% | $0 | |
| DM | 2025-03-04 | 2025-03-03+ | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | S - Sale | $7.96 | -124.9K | 680.5K | -16% | -$994.4K |
| DM | 2025-03-04 | 2025-02-28+ | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | COO | A - Grant | $0.00 | +218.3K | 669.8K | +48% | $0 |
| 2024-03-07 | 2024-03-06 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | EVP, Ops, Strategy | S - Sale | $5.51 | -40.7K | 584.1K | -7% | -$224.1K | |
| 2024-02-22 | 2024-02-20 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | EVP, Ops, Strategy | A - Grant | $0.00 | +216.7K | 624.7K | +53% | $0 | |
| 2023-03-06 | 2023-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | EVP, Ops, Strategy | A - Grant | — | +271.1K | 403.1K | +205% | — | |
| 2022-11-23 | 2022-11-21 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Ex VP, Internal Ops | P - Purchase | $4.66 | +10.0K | 27.9K | +56% | +$46.6K | |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Ex VP, Intern'l Ops | A - Grant | $0.00 | +8,500 | 19.3K | +79% | $0 |
| D | 2022-03-04 | 2022-03-02 | AUPH | Aurinia Pharmaceuticals Inc. | Donley Matthew Maxwell | Ex VP, Intern'l Ops | S - Sale | $12.01 | -3,052 | 16.2K | -16% | -$36.7K |
Purchase Sale Sale after option exercise All abbreviations